Corton Capital’s ClearPoint Neuro CLPT Stock Holding History

Corton Capital’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-24,494	Closed	-$132K	–	515
2024 Q2	$132K	Buy	+24,494	New	+$142K	0.07%	434

Other funds holding CLPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CWM

Cahill Wealth Management Portage, Michigan $196M AUM 8.5% 1-Year Est. Return

Corton Capital's CLPT Position: Q3 2024 in Review

Corton Capital sold out of ClearPoint Neuro (CLPT) in Q3 2024, closing a stake of 24,494 shares — an estimated $132K sold.

Corton Capital first reported a position in CLPT in Q2 2024 and held it in 1 quarter. The position peaked at $132K in Q2 2024. 78 funds tracked by Wall St. Rank hold CLPT as of Q3 2024.

Corton Capital reported no remaining ClearPoint Neuro position as of Q3 2024 after selling out during the quarter.
Corton Capital sold 24,494 ClearPoint Neuro shares in Q3 2024, an estimated $132K.
Corton Capital first reported a position in ClearPoint Neuro in Q2 2024 and held it in 1 quarter.
Corton Capital's ClearPoint Neuro position peaked at $132K in Q2 2024.
78 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2024.

Based on Corton Capital's 13F filing for Q3 2024, filed 14 Nov 2024.